The board-certified fellowship-trained physicians at Florida Eye Specialists are recognized in their respective ophthalmic subspecialties for their leadership and contributions to the advancement of eye care. Our doctors are engaged in clinical trials and frequently lecture to other eye doctors locally and at national meetings. They were some of the first to introduce many state-of-the-art surgical techniques and eye procedures to Northeast Florida in a myriad of ophthalmic trials. Trials involved cataracts, glaucoma, diabetes, dry eye, wet macular degeneration, and herpes.
Concierge Service
Because the qualifications for each Clinical Research Trial are very thorough and unique, we take the time to walk you through what exactly it would mean to participate.
Interested in participating or partnering with us? Call 904-740-3940 or email us at FES@roviaclinical.com.
Featured Research
Florida Eye Specialists partnered with Alcon on an investigator-initiated trial evaluating how intraocular lens (IOL) centration and tilt affect visual performance with a non-diffractive extended depth of focus (EDOF) lens. Watch Dr. Shetty discuss the study and its findings.
Our Partners
Now Partnered With Rovia
Our team also works with multiple pharmaceutical, medical device companies, and academic institutions such as Alcon, Tomey, AbbVie, Dompe, Amgen, Tarsus, New York University Grossman School of Medicine, and many others.
Current Clinical Trials
Current research trials will be listed below. Click on a study link to learn more. The following links will direct you to the trial description on ClinicalTrials.gov unless otherwise noted. All links open in a new window.
Currently Enrolling
GENERAL OPHTHALMOLOGY
- No current trials are available for enrollment at this time.
CATARACTS
- Post Market Clinical Follow-up (PMCF) Study of Clareon Vivity & Clareon PanOptix | Now Enrolling
- Effect of Intraocular Lens (IOL) Centration and Tilt on Visual Performance With Clareon® Vivity® IOL Implantation | Now Enrolling
GLAUCOMA
- MRCT Evaluating NCX 470 vs. Latanoprost in Subjects With Open-Angle Glaucoma or Ocular Hypertension (Denali) | Now Enrolling
- Study to Assess Change in Disease Activity and Adverse Events of Ab Externo Approach for Glaucoma Gel Stent | Now Enrolling
- Safety Assessment of T4090 Eye Drops in Ocular Hypertensive or Glaucomatous Patients | Coming Soon
DRY EYE
- No current trials are available for enrollment at this time.
DIABETIC MACULAR EDEMA
- Study of the Efficacy and Safety of OCS-01 Eye Drops in Subjects With Diabetic Macular Edema (DIAMOND-2) | Now Enrolling
DIABETIC RETINOPATHY
- No current trials are available for enrollment at this time.
WET AGE-RELATED MACULAR DEGENERATION
- No current trials are available for enrollment at this time.
Enrollment Complete
- Efficacy and Safety of Lonigutamab in Subjects With Thyroid Eye Disease (TED) | Enrollment Complete
- Zoster Eye Disease Study (ZEDS) | Enrollment Complete
- Post-Approval Study of the TECNIS SYMFONY® Toric Lenses (ANCORA) | Enrollment Complete
- Post-Approval Study of the CyPass System | Enrollment Complete
- Travoprost Intraocular Implant Clinical Study (Glaukos) | Enrollment Complete
- ALY688 Ophthalmic Solution Oasis-1 Trial | Enrollment Complete
- Diabetic Retinopathy Focus Trial | Enrollment Complete
- Lupin Treatment LUBT010 for Neovascular Age-Related Macular Degeneration | Enrollment Complete